A campaign for the Neuroendocrine Tumor Research Foundation

Discovery

Accelerate the search for cures
Expand innovative research for breakthrough discoveries

Progress

More treatment options
Better quality of life

Awareness

Support for patient and families
Information and education

What Your Donation Sparks

The Neuroendocrine Tumor Research Foundation has invested more than $20 million in research to increase our understanding of neuroendocrine tumors and develop insights to improve treatments.

Funding basic, translational and clinical research at leading institutions around the world.

Attracting the most influential, global scientists to advance our understanding and recruiting new researchers to NETs

Supporting team science to harness broad a range of perspectives in solving fundamental scientific questions

Leveraging revolutionary advances in biotechnology, molecular profiling and bioengineering.

Providing educational conferences across the U.S. for patients and caregivers while posting videos of these talks on our website for viewing anytime

Want to discuss a special gift?

NETRF - Susan Payson CDO-07503

Susan Payson

Chief Development Officer – 617.946.1782

NETRF CEO Elyse Gellerman

Elyse Gellerman

Chief Executive Officer – 617.946.1783

See how Dave McCoy’s experience of leaving cancer behind gives us hope

Your gift can help improve, extend, and save lives

Every Gift Will Be Matched

The Spark Hope campaign is fueled by a generous match by the Margie and Robert E. Petersen Foundation.
Your gift to the Neuroendocrine Tumor Research Foundation today will be doubled.

$
0
Campaign Gifts
As of 9/27/18
$
0
Campaign Total
As of 9/27/18
TESTIMONIALS

What Our Donors Are Saying

“I give to NETRF because my wife was diagnosed 20 years ago. And I want to accomplish what any husband would is to have an effective treatment and a cure for my wife’s disease. And we have seen remarkable progress made. But we will only get to a cure if we all work together and do whatever it takes.”

“I gave my first gift to NETRF because I realized that if you’re not in this patient group or among those people who know a patient with this disease, you’ve probably never heard of it and probably not going to give. I was among those patients who decided it’s my responsibility to support this organization because without us? Who?”

Joe Li, MD
Chair NETRF Board of Directors

Carol Branaman
Vice Chair, NETRF Board of Directors